Mediplantex National Pharmaceutical JSC (HNX:MED)

HNX:MED Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 19, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	312,732	322,660	335,070	260,610	187,775	244,924
Market Cap Growth	99.19%	-3.70%	28.57%	38.79%	-23.33%	-
Enterprise Value	333,596	332,302	335,404	170,199	147,414	284,398
Last Close Price	25200.00	24660.94	24749.42	18879.37	26565.12	24861.10
PE Ratio	25.83	21.16	28.53	40.94	50.11	10.03
PS Ratio	0.88	0.73	0.83	0.65	0.55	0.47
PB Ratio	0.96	0.98	1.02	0.81	1.13	1.35
P/TBV Ratio	0.96	0.98	1.02	0.81	1.13	1.35
P/FCF Ratio	4.51	8.57	-	-	24.24	4.05
P/OCF Ratio	7.12	6.77	-	9.94	3.02	2.74
EV/Sales Ratio	0.94	0.75	0.83	0.42	0.43	0.55
EV/EBITDA Ratio	14.79	11.04	14.83	9.12	8.00	7.64
EV/EBIT Ratio	19.07	14.97	23.65	19.71	16.58	10.45
EV/FCF Ratio	4.81	8.82	-	-	19.03	4.70
Debt / Equity Ratio	0.15	0.08	0.20	0.28	0.41	0.44
Debt / EBITDA Ratio	2.21	0.92	2.85	4.87	3.72	2.16
Debt / FCF Ratio	0.72	0.74	-	-	8.86	1.33
Asset Turnover	0.74	0.84	0.64	0.67	0.68	0.96
Inventory Turnover	3.32	3.68	3.12	3.38	3.05	3.60
Quick Ratio	0.55	0.73	0.69	0.83	0.70	0.87
Current Ratio	1.54	1.46	1.32	1.22	1.04	1.21
Return on Equity (ROE)	3.71%	4.63%	3.62%	2.61%	2.16%	13.93%
Return on Assets (ROA)	2.27%	2.62%	1.41%	0.91%	1.09%	3.12%
Return on Capital (ROIC)	2.83%	3.70%	2.20%	1.67%	2.24%	6.46%
Return on Capital Employed (ROCE)	5.40%	6.70%	4.30%	2.70%	5.40%	15.00%
Earnings Yield	3.87%	4.72%	3.50%	2.44%	2.00%	9.97%
FCF Yield	22.19%	11.68%	-25.22%	-34.93%	4.13%	24.71%
Dividend Yield	3.57%	-	3.64%	2.65%	0.94%	-
Payout Ratio	119.73%	72.28%	54.72%	138.49%	354.43%	38.11%
Buyback Yield / Dilution	0.03%	-	-32.18%	-49.59%	0.05%	0.01%
Total Shareholder Return	3.60%	-	-28.54%	-46.94%	0.99%	0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.